Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians Emanuel RaschiSimone RossiLuciano Potena Review Article Open access 21 June 2023 Pages: 819 - 833
Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study David R. CornblathPieter A. van Doornthe ProCID Investigators Original Research Article Open access 28 June 2023 Pages: 835 - 845
Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical Utility Vijay KaraGreg PowellAndrew Bate Original Research Article Open access 03 August 2023 Pages: 847 - 855
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study Michele FusaroliFrancesco SalvoCharles Khouri Original Research Article Open access 08 July 2023 Pages: 857 - 866
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand Muireann WaltonVadim PletzerTimothy Hanlon Original Research Article Open access 09 August 2023 Pages: 867 - 879
Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment Yamin ShuLei WangQilin Zhang Original Research Article 07 July 2023 Pages: 881 - 895
The QTc-Bazett Interval in Former Very Preterm Infants in Adolescence and Young Adulthood is Not Different from Term-Born Controls Jill VanthienenMarine Vassilev PetrovKarel Allegaert Original Research Article Open access 28 July 2023 Pages: 897 - 904
Use of Bisphosphonates and the Risk of Skin Ulcer: A National Cohort Study Using Data from the French Health Care Claims Database Clément Jambon-BarbaraClaire BernardeauCharles Khouri Original Research Article 02 August 2023 Pages: 905 - 916
Comment on: “Deliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System” Emiliano CappelloGiulia ValdiserraMarco Tuccori Letter to the Editor 12 August 2023 Pages: 917 - 918
Authors’ Reply to Cappello et al. Comment on: “Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System” Michele FusaroliGuido PellettiElisabetta Poluzzi Letter to the Editor 12 August 2023 Pages: 919 - 920